
Rebus Holdings, Inc.
Share · US75619J1034 (OTC)
No Price
Closing Price OTC 04.11.2025:
0,0001 USD
04.11.2025 21:00
Current Prices from Rebus Holdings, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
RBSH
|
USD
|
04.11.2025 21:00
|
0,0001 USD
| 0,00 USD |
Company Profile for Rebus Holdings, Inc. Share
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Company Data
Name Rebus Holdings, Inc.
Company Rebus Holdings, Inc.
Website
https://www.rebus-corp.com
Primary Exchange
UTC
ISIN US75619J1034
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Raul Silvestre
Country United States of America
Currency USD
Employees 0,0 T
Address 2629 Townsgate Road, 91361 Westlake Village
IPO Date 2009-11-04
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | RBSH |
More Shares
Investors who hold Rebus Holdings, Inc. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.


